trending Market Intelligence /marketintelligence/en/news-insights/trending/pCk4vDSE2VvGZjOv7ZVjIA2 content esgSubNav
In This List

Zosano appoints board member

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Zosano appoints board member

Zosano Pharma Corp. appointed Kenneth Greathouse to its board of directors.

Greathouse is the co-founder and has served as CEO of Manchester Pharmaceuticals, which was sold to Retrophin Inc. in 2014.